Picture of Heidelberg Pharma AG logo

HPHA — Heidelberg Pharma AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Heidelberg Pharma 9-Month Net Loss Of EUR 7.4 Million

Oct 11 (Reuters) - Heidelberg Pharma AG  WL6G.DE :
    * 9-MONTH SALES REVENUE AND INCOME TOTALING EUR 3.5 MILLION
(PREVIOUS YEAR: EUR 1.6 MILLION)
    * 9-MONTH SALES REVENUE OF EUR 3.1 MILLION (PREVIOUS YEAR:
EUR 1.4
MILLION)
    * NET LOSS FOR FIRST NINE MONTHS OF FISCAL YEAR FELL TO EUR
7.4
MILLION (PREVIOUS YEAR: EUR 7.6 MILLION)
    * EXPECTS TO GENERATE BETWEEN EUR 3.5 MILLION AND EUR 4.5
MILLION
IN SALES REVENUE AND OTHER INCOME IN 2018
    * EBIT FOR 2018 FISCAL YEAR ARE PROJECTED TO BE BETWEEN EUR
-10.0
MILLION AND EUR -12.0 MILLION

Source text for Eikon:  ID:nEQ9yxB40a 
Further company coverage:  WL6G.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Heidelberg Pharma AG

See all news